Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient Isolation and Functional Characterization of Niche Cells from Human Corneal Limbus. | Int J Mol Sci | 2022 | 35269891 | PubTator, text mining | PubMed |
| Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. | Int J Mol Sci | 2022 | 35269844 | PubTator, text mining | PubMed |
| Interferon-gamma induces melanogenesis via post-translational regulation of tyrosinase. | Pigment Cell Melanoma Res | 2022 | 35266648 | PubTator, text mining | PubMed |
| Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells. | Theranostics | 2022 | 35265199 | PubTator, text mining | PubMed |
| Genetic Characterization of Colistin-Resistant Salmonella enterica ST34 Co-Harbouring Plasmid-Borne mcr-1, bla CTX-M-15 and bla KPC-2 Recovered from a Paediatric Patient in Shenzhen, China. | Infect Drug Resist | 2022 | 35264859 | PubTator, text mining | PubMed |
| Biological response of adrenal carcinoma and melanoma cells to mitotane treatment. | Oncol Lett | 2022 | 35261634 | PubTator, text mining | PubMed |
| Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy. | J Neurol Sci | 2022 | 35259554 | PubTator, text mining | PubMed |
| Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy. | Clin Cancer Res | 2022 | 35247927 | PubTator, text mining | PubMed |
| Identification of (Z)-2-benzylidene-dihydroimidazothiazolone derivatives as tyrosinase inhibitors: Anti-melanogenic effects and in silico studies. | Comput Struct Biotechnol J | 2022 | 35242283 | PubTator, text mining | PubMed |
| Integrative analysis of transcriptomics and metabolomics to reveal the melanogenesis pathway of muscle and related meat characters in Wuliangshan black-boned chickens. | BMC Genomics | 2022 | 35236293 | PubTator, text mining | PubMed |
| A novel mouse strain optimized for chronic human antibody administration. | Proc Natl Acad Sci U S A | 2022 | 35235456 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. | Pigment Cell Melanoma Res | 2022 | 35229492 | PubTator, text mining | PubMed |
| Melasma: The need for tailored photoprotection to improve clinical outcomes. | Photodermatol Photoimmunol Photomed | 2022 | 35229368 | PubTator, text mining | PubMed |
| Oncolytic viruses in melanoma. | Front Biosci (Landmark Ed) | 2022 | 35227006 | PubTator, text mining | PubMed |
| Loss of EMP2 Inhibits Melanogenesis of MNT1 Melanoma Cells via Regulation of TRP-2. | Biomol Ther (Seoul) | 2022 | 35221300 | PubTator, text mining | PubMed |
| A B-cell or a key player? The different roles of B-cells and antibodies in melanoma. | Pigment Cell Melanoma Res | 2022 | 35218154 | PubTator, text mining | PubMed |
| Metformin's Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP). | Int J Mol Sci | 2022 | 35216316 | PubTator, text mining | PubMed |
| Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support. | Int J Mol Sci | 2022 | 35216165 | PubTator, text mining | PubMed |
| (+)-Magnolin Enhances Melanogenesis in Melanoma Cells and Three-Dimensional Human Skin Equivalent; Involvement of PKA and p38 MAPK Signaling Pathways. | Planta Med | 2022 | 35211932 | PubTator, text mining | PubMed |
| Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. | Front Immunol | 2022 | 35211124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=36